Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Fabry
MPS I
Disease Information
Management of MPS I Disease
Symptomatic or corrective management
Specific therapies
About Aldurazyme®
Aldurazyme® clinical trial summary
Reconstitution & Administration
Importance of Compliance
Summary of Product Characteristics
Medical Information Services
MPS I Registry
Practical Info
Request Materials
Pompe

 



 

Reconstitution and administration of Aldurazyme®

Please see the full prescribing information in Dutch or in French (PDF) for Aldurazyme®.

The recommended dosage regimen of Aldurazyme® (laronidase) is 100 U/kg of body weight administered once weekly as an intravenous infusion. Pretreatment with antipyretics and/or antihistamines is recommended 60 minutes prior to the start of the first few infusions, upon re-administration following interruption of treatment, and if otherwise clinically indicated.[1]

The total volume of the infusion is determined by the patient’s body weight and should be delivered over approximately three to four hours.

Patients with a body weight of 20 kg or less should receive a total volume of 100 ml.

Patients with a body weight of greater than 20 kg should receive a total volume of 250 ml.

The initial infusion rate of 2 U/kg/hr may be incrementally increased every 15 minutes during the first 1-1.5 hours, as tolerated, until a maximum infusion rate of 43U/kg/hr is reached.

The maximum rate is then maintained for the remainder of the infusion (2-3 hours). [1]

For Patients weighing 20 kg or less than 20 kg: [1]

Total Volume of Aldurazyme Infusion = 100 ml

2 ml/hr x 15 minutes
(equivalent to 2 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

4 ml/hr x 15 minutes
(equivalent to 4 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

8 ml/hr x 15 minutes
(equivalent to 8 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

16 ml/hr x 15 minutes
(equivalent to 16 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

32 ml/hr x 15 minutes
(equivalent to 32 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

43 ml/hr

(equivalent to 43 U/kg/h)

For the remainder of the infusion

For Patients weighing more than 20 kg: [1]

Total Volume of Aldurazyme Infused = 250 ml

5 ml/hr x 15 minutes
(equivalent to 2 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

10 ml/hr x 15 minutes
(equivalent to 4 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

20 ml/hr x 15 minutes
(equivalent to 8 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

40 ml/hr x 15 minutes
(equivalent to 16 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

80 ml/hr x 15 minutes
(equivalent to 32 U/kg/h)

Obtain vital signs; if stable, increase the rate to…

107 ml/hr
(equivalent to 43 U/kg/h)

For the remainder of the infusion.

References:

1. Summary of Product Characteristics Aldurazyme®

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with Cerezyme®

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with Fabrazyme® significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease